Malawi vs Uganda: HIV/AIDS deaths averted by antiretroviral therapy
Malawi
53,389 deaths
in 2024
Uganda
82,921 deaths
in 2024
Malawi rank
9th
Uganda rank
6th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Malawi
- Uganda
How they compare
Uganda currently reports 82,921 deaths against 53,389 deaths in Malawi, a difference of 29,532 deaths.
That makes Uganda's figure about 1.6 times Malawi's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Uganda ahead.
Malawi ranks 9th and Uganda ranks 6th of 157 countries.
Uganda has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Malawi | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 9,707 deaths | 12,859 deaths | 3,153 deaths | Uganda |
| 2010s | 46,122 deaths | 56,072 deaths | 9,950 deaths | Uganda |
| 2020s | 53,202 deaths | 81,329 deaths | 28,127 deaths | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Malawi or Uganda?
- Uganda, at 82,921 deaths against 53,389 deaths in Malawi as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Malawi and Uganda?
- 29,532 deaths, with Uganda ahead.
- How many years of comparable data are there for Malawi and Uganda?
- 35 years are reported by both, from 1990 to 2024.
- How do Malawi and Uganda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Malawi ranks 9th and Uganda ranks 6th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.